A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
Cognitive neuroscientist Eleanor Maguire, PhD, whose studies of London taxi drivers' brains helped transform memory research, ...
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer ...
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
Quincy man becomes first Alzheimer’s patient to try nasal spray drug: ‘I’m hoping like heck’
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results